Anti-Il-20 Monoclonal Antibody Alleviates Inflammation in Oral Cancer and Suppresses Tumor Growth

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-12-0276
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Anti-Il-20 Monoclonal Antibody Suppresses Prostate Cancer Growth and Bone Osteolysis in Murine Models

PLoS ONE
Multidisciplinary
2015English

Anti-Il-20 Monoclonal Antibody Inhibited Inflammation and Protected Against Cartilage Destruction in Murine Models of Osteoarthritis

PLoS ONE
Multidisciplinary
2017English

Combined Yeast-Derived Β-Glucan With Anti-Tumor Monoclonal Antibody for Cancer Immunotherapy

Experimental and Molecular Pathology
Forensic MedicinePathologyClinical BiochemistryMolecular Biology
2009English

Anti-Tumor Activity of an Anti-Endoglin Monoclonal Antibody Is Enhanced in Immunocompetent Mice

International Journal of Cancer
Cancer ResearchOncology
2008English

Treatment of Atopic Dermatitis With Tralokinumab, an Anti–IL-13 Monoclonal Antibody

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

An Anti-Cd133 Monoclonal Antibody CMab-43 Exerts Anti-Tumor and Anti-Metastasis Activities for Colon Cancers

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Salubrinal Acts as a Dusp2 Inhibitor and Suppresses Inflammation in Anti-Collagen Antibody-Induced Arthritis

Cellular Signalling
Cell Biology
2015English

Effect of in Vivo Administration of Anti-Ctla-4 Monoclonal Antibody and IL-12 on the Induction of Low-Dose Oral Tolerance

Clinical and Experimental Immunology
AllergyImmunology
2002English

S100A4 Blockage Alleviates Agonistic Anti-Cd137 Antibody-Induced Liver Pathology Without Disruption of Anti-Tumor Immunity

OncoImmunology
OncologyAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy